Atlanta, GA, United States of America

Jialei Chen

This inventor holds 1 USPTO granted patent. Top assignee: Georgia Tech Research Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jialei Chen. Retrieved from https://idiyas.com/inventor/jialei-chen-edztrkf3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jialei Chen and Impedance-Based Cell Counting

Introduction

Jialei Chen is an inventor associated with Atlanta, Georgia, and Georgia Tech Research Corporation. His patent work focuses on using impedance-based biosensors to determine viable cell counts.

Latest Patents

Chen is named on one patent, “Methods of Determining Viable Cell Count and Impedance-Based Biosensors for the Same.” The disclosed system includes an electrode, a meter, a processor, and memory containing instructions. It measures the electrode’s impedance, derives electrical properties from that measurement, and uses those properties to calculate a viable cell count. Chen’s listed portfolio includes 1 patent.

Career Highlights

The patent connects Chen’s work with biosensor technology and methods for assessing cell viability. Georgia Tech Research Corporation is identified as his affiliated company.

Collaborations

Zhaonan Liu and Xuzhou Jiang are identified as Chen’s coworkers. Their names also appear in the context of his professional collaborations.

Conclusion

Jialei Chen’s patent describes an impedance-based approach to calculating viable cell counts, reflecting his association with biosensor innovation at Georgia Tech Research Corporation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…